Miparanum, Roger B.

HRN: 06-23-09  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/25/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/25/2022
12/02/2022
IV
2.25gram
Q8hrs
Complicated UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: